Background Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved
by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) …

Objective: To investigate potential effects of continuous subcutaneous insulin infusion (CSII)
compared with multiple daily injections (MDI) on glycemic control in children with type 1 …

Since 2005, the Diabetes Poland (Polskie Towarzystwo Diabetologiczne, PTD) prepares
and publishes annually its guidelines on the management of diabetic patients. The idea of …

Background Intensified insulin delivery using multiple daily injections ( MDI ) or continuous
subcutaneous insulin infusion ( CSII ) is recommended in children with type 1 diabetes ( T1D …

Szypowska A, Skórka A. The risk factors of ketoacidosis in children with newly diagnosed
type 1 diabetes mellitus. Background and aims: Diabetic ketoacidosis (DKA) is still a severe …

Background: An insulin pump is an advanced technology offering new options of bolus –
normal (N), dual wave (D‐W) or square wave (S‐W) bolus to deliver mealtime insulin. …

Background: Atopic allergy is among the immune tolerance-related disorders resulting from
a failure of the regulatory network. Regulatory T cells (Tregs) play a leading role in the …

Introduction The POInT study, an investigator initiated, randomised, placebo-controlled,
double-blind, multicentre primary prevention trial is conducted to determine whether daily …

Importance The incidence of diabetes in childhood has increased during the COVID-19
pandemic. Elucidating whether SARS-CoV-2 infection is associated with islet autoimmunity, …

Aim. The aim of this study was to evaluate the incidence of diabetic ketoacidosis in children
and adolescents with newly diagnosed type 1 diabetes in 2006-2007 and 2013-2014. …